Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Oncology Reports|July 6, 2006
Pharmacokinetics of S-1 in patients with peritoneal dissemination of gastric cancerTakashi Oshima, Roppei Yamada, Shinsuke Hatori, et al.
Expert Opinion on Investigational Drugs|April 25, 2009
Synthesis and biological evaluation of novel hydrazide based cytotoxic agentsFedora Grande, Roppei Yamada, Xuefei Cao, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 2003
[Cisplatin, 5-fluorouracil, and high-dose leucovorin for advanced esophageal cancer]Roppei Yamada, Yuji Yamamoto, Soichiro Morinaga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 18, 2006
[Low-dose weekly paclitaxel therapy proved useful for a case of recurrent gastric cancer with clinically latent hepatic cirrhosis]Roppei Yamada, Takashi Ohshima, Tsutomu Sato, et al.
Cancer Biology & Therapy|December 22, 2009
Biological evaluation of paclitaxel-peptide conjugates as a model for MMP2-targeted drug deliveryRoppei Yamada, Maya B Kostova, Ravi Kumar Anchoori, et al.
Anti-Cancer Drugs|March 27, 2009
Combination effects of SC144 and cytotoxic anticancer agentsTakashi Oshima, Xuefei Cao, Fedora Grande, et al.
Surgical Case Reports|August 11, 2025
A Case of Solitary Fibrous Tumor of the Greater Omentum Incidentally Detected during Preoperative Evaluation for Thyroid CancerRei Hatayama, Yasushi Rino, Yoshio Kure, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 18, 2002
[Intraoperative radiotherapy (IORT) for unresectable stage IVb pancreatic cancer]Hiroyuki Saeki, Yukio Sugimasa, Roppei Yamada, et al.
Hepato-Gastroenterology|November 26, 2011
Usefulness of multidisciplinary therapy combining neoadjuvant chemotherapy with S-1 plus cisplatin and postoperative sequential chemotherapy in patients with scirrhous gastric cancerTakashi Oshima, Chikara Kunisaki, Tsutomu Sato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 14, 2006
[Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy]Shinsuke Hatori, Chikara Kunisaki, Hidetaka Ono, et al.
Pageof 5